SMALL LYMPHOCYTIC LEUKEMIA (SLL)
Clinical trials for SMALL LYMPHOCYTIC LEUKEMIA (SLL) explained in plain language.
Never miss a new study
Get alerted when new SMALL LYMPHOCYTIC LEUKEMIA (SLL) trials appear
Sign up with your email to follow new studies for SMALL LYMPHOCYTIC LEUKEMIA (SLL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested to control returning blood cancer
Disease control Recruiting nowThis study is testing whether a combination of three drugs—pirtobrutinib, venetoclax, and obinutuzumab—can help control chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back after prior treatment. It will enroll about 40 adults who have been tr…
Matched conditions: SMALL LYMPHOCYTIC LEUKEMIA (SLL)
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug combo aims to wipe out cancer cells in blood cancers
Disease control Recruiting nowThis study is testing a combination of three drugs—zanubrutinib, obinutuzumab, and venetoclax—for people with untreated CLL or SLL. The main goal is to see how many patients achieve a deep response where no cancer cells can be detected in their blood or bone marrow. It aims to co…
Matched conditions: SMALL LYMPHOCYTIC LEUKEMIA (SLL)
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC